• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 6L45-21
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/03/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.Patient identifier complete sid: (b)(6).
 
Event or Problem Description
The customer reported a falsely decreased total bilirubin result generated on the architect c8000 on one patient.Results provided: sid (b)(6) = (b)(6).No impact to patient management was reported.
 
Additional Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for lot 56889uq02.Trending review determined no trends for falsely depressed results for the product.Return testing was not completed as returns were not available.To evaluate the historical performance of reagent lot 56889uq02, worldwide field data was reviewed.The median population result for the lot is within the established control limits.Therefore, no unusual reagent lot performance was identified.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no deficiency of the architect total bilirubin reagent lot number 56889uq02 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Common Device Name
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
MDR Report Key11290411
Report Number3016438761-2021-00040
Device Sequence Number11887896
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (Y/N)N
Initial Reporter CountryMY
PMA/510(K) Number
K121985
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2021
Device Model Number6L45-21
Device Catalogue Number06L45-21
Device Lot Number56889UQ02
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/20/2021
Supplement Date Received by Manufacturer02/24/2021
Initial Report FDA Received Date02/07/2021
Supplement Report FDA Received Date02/24/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C8000 REFURB-SINGAP, 01G06-88, C801223
-
-